[Frontiers in Bioscience 1, d248-265, September 1, 1996]
Reprints
PubMed
CAVEAT LECTOR



XENOTRANSPLANTATION - STATE OF THE ART

D.K.C. Cooper, MA, PhD, MD, MS, FRCS, FACC, FACS

Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA

Received 07/16/96; Accepted 08/12/96; On-line 09/01/96

7. REFERENCES

1. A Jazzar, S Fagiuoli, S Sisson, N Zuhdi & D K C Cooper: Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Clin Transplantation 9, 334-339, (1995)

2. L Mischke, S Sisson, D K C Cooper & N Zuhdi: Cardiac transplantation in patients aged 60 years or older. J Okla State Med Assoc 89, 22-25 (1996)

3. S Sisson, A Jazzar, L Mischke, DKC Cooper & N Zuhdi: How many endomyocardial biopsies are necessary in the first year after heart transplantation? Transplant Int 9, 243-247 (1996)

4. DKC Cooper: Xenografting: how great is the clinical need? Xeno 1, 25-26 (1993)

5. DKC Cooper, E Kemp, K Reemtsma & DJG White: Xenotransplantation, (First edition), Springer, Heidelberg, (1991)

6. DKC Cooper, E Kemp, JL Platt & DJG White: Xenotransplantation, (Second edition), Springer, Heidelberg In press

7. RY Calne: Organ transplantation between widely disparate species. Transplant Proc 2, 550-553 (1970)

8. AG Rose, DKC Cooper, PA Human, H Reichenspurner & B Reichart: Histopathology of hyperacute rejection of the heart - experimental and clinical observations in allografts and xenografts. J Heart Transplant 10, 223-234 (1991)

9. AM Sadeghi, RC Robbins, CR Smith, RA Kurlansky, RE Michler, K Reemtsma & EA Rose: Cardiac xenograft survival in baboons treated with cyclosporine in combination with conventional immunosuppression. Transplant Proc 19, 1149- 1152 (1987)

10. PA Kurlansky, AM Sadeghi, RE Michler, CR Smith, CC Marboe, WA Thomas, L Coppey & EA Rose: Comparable survival of intra-species and cross-species primate cardiac transplants. Transplant Proc 19, 1067-1071 (1987)

11. DKC Cooper, PA Human, AG Rose, J Rees, M Keraan, B Reichart & E Dutoit: The role of ABO blood group compatibility in heart transplantation between closely-related animal species An experimental study using the vervet monkey-to-baboon cardiac xenograft model. J Thorac Cardiovasc Surg 97, 447-455 (1989)

12. H Reichenspurner, PA Human, DH Boehm, AG Rose, R May, DKC Cooper, P Zilla & B Reichart: Optimalization of immunosuppression after xenogeneic heart transplantation in primates. J Heart Transplant 8, 200-208 (1989)

13. L Mieles, Y Ye, Y Luo, T Kobayashi, SF Li, M Niekrasz, S Kosanke, D Smith & DKC Cooper: Auxiliary liver allografting and xenografting in the nonhuman primate Transplantation 59, 1670-1676 (1995)

14. JL Platt & FH Bach: Mechanism of tissue injury in hyperacute xenograft rejection In Xenotransplantation, (First edition), Eds: DKC Cooper, E Kemp, K Reemtsma & DJG White, Springer, Heidelberg, 69-79, (1991)

15. L Makowka, DV Cramer, A Hoffman, M Breeda, L Sher, G Eiras-Hreha, PJ Tuso, C Yasunaga, CA Cosenza, G Du Wu, FA Chapman & L Podesta: The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 59, 1654-1659 (1995)

16. AFM Schaapherder, HG Gooszen, M-TJW Te Bulte & MR Daha: Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Transplantation 60, 287-291 (1995)

17. JR Leventhal, AP Dalmasso, JW Cromwell, JL Platt, CJ Manivel, RM Bolman III & AJ Matas: Prolongation of cardiac xenograft survival by depletion of complement Transplantation 55, 857-865 (1993)

18. T Kobayashi, S Taniguchi, Y Ye, M Niekrasz, S Kosanke, FA Neethling, LJ Wright, AG Rose, DJG White, WW Hancock & DKC Cooper: Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor Transplant Proc 28, 560 (1996)

19. FH Bach, SC Robson, H Winkler, C Ferran, KM Stuhlmeier, CJ Wrighton & WW Hancock: Barriers to xenotransplantation. Nature Med 1, 869-873 (1995)

20. L Inverardi, M Samaja, F Marelli, JR Bender & R Pardi: Cellular immune recognition of xenogeneic vascular endothelium Transplant Proc 24, 459-461 (1992)

21. WW Hancock & FH Bach: The immunopathology of discordant xenograft rejection Xeno 2, 68-74 (1994)

22. AH Good, DKC Cooper, AJ Malcolm, RM Ippolito, E Koren, FA Neethling, Y Ye, N Zuhdi & LR Lamontagne: Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man. Transplant Proc 24, 559-562 (1992)

23. DKC Cooper: Depletion of natural antibodies in nonhuman primates - a step towards successful discordant xenografting in humans. Clin Transplantation 6, 178-183 (1992)

24. DKC Cooper, AH Good, E Koren, R Oriol, AJ Malcolm, RM Ippolito, FA Neethling, Y Ye, E Romano & N Zuhdi: Identification of alpha-galactosyl and other carbohydrates that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1, 198-205 (1993)

25. R Oriol, Y Ye, E Koren & DKC Cooper: Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 56, 1433- 1442 (1993)

26. DKC Cooper, E Koren, & R Oriol: Oligosaccharides and discordant xenotransplantation. Immunol Rev 141, 31-58 (1994)

27. MS Sandrin, HA Vaughan, PL Dabkowski & IFC Mckenzie: Anti-pig IgG antibodies in human serum react predominantly with Gal(alpha1-3)Gal epitopes. Proc Natl Acad Sci USA 90, 11391-11395 (1993)

28. U Galili: Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 14, 480-482 (1993)

29. U Galili, SB Shohet, E Kobrin, CLM Stults & BA Macher: Man, apes and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 263, 17755-17762 (1988)

30. M Satake, N Kawagishi, L Rydberg, BE Samuelsson, A Tibell, C-G Groth & E Moller: Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters Main antibody reactivity against alpha- linked galactose-containing epitopes. Xenotransplantation 1, 89-101 (1994)

31. M Satake, M Kumagai-Braesch, N Kawagishi, A Tibell, C-G Groth & E Moller: Kinetics and character of xenoantibody formation in diabetic patients transplanted with fetal porcine islet cell clusters. Xenotransplantation 1, 24-35 (1994)

32. L Rydberg, TDH Cairns, C-G Groth, ML Gustavsson, EC Karlsson, E Moller, M Sataki, A Tibbel & BE Samuelsson: Specificities of human IgM and IgG anti-carbohydrate xenoantibodies found in the sera of diabetic patients grafted with fetal pig islets. Xenotransplantation 1, 69-79 (1994)

33. U Galili, RE Mandrell, RM Hamadeh, SB Shohet & JM Griffiss: The interaction between the human natural anti- agalactosyl IgG (anti-Gal) and bacteria of the human flora. Infect Immun 57, 1730-1737 (1988)

34. O Minanov, S Itescu, P Kwiatkowski, F Neethling, DKC Cooper & R Michler: Pre-formed and induced anti-Gal cytotoxic antibodies in newborn humans and baboons. J Heart Lung Transplant 15, S101, (Abstract 249) (1996)

35. B Gridelli, S Gatti, A Piazzini, P Reggiani, M Langer, W Deklerk, JH Stark, P Bonara, S Cristina & L Campanati: Xenogeneic orthotopic liver transplantation in nonhuman primates. Transplant Proc 25, 457-461 (1993)

36. MF Donato, E Arosio, E Berti, S Gatti, A Piazzini, M Colledan, G Rossi, LR Fassati, D Galmarini & B Gridelli: Immunopathology of liver allografts and xenografts in nonhuman primates. Transplant Proc 25, 850-855 (1993)

37. DKC Cooper, PA Human & B Reichart: Prolongation of cardiac xenograft (vervet monkey-to-baboon) function by a combination of total lymphoid irradiation and immunosuppressive drug therapy. Transplant Proc 19, 4441-4442 (1987)

38. R Panza, M Roslin, M Coons, I Alexandropoulos, JN Cunningham, A Norin & R Tranbaugh: Successful cardiac xenogeneic transplantation in primates using total lymphoid irradiation. Eur J Cardiothorac Surg 5, 161-163 (1991)

39. AJ Norin, MS Roslin, A Panza, MS Coons, CK Chen, YD Kim, A Strashun, JN Cunningham & RF Tranbaugh: TLI induces specific B cell unresponsiveness and long-term monkey heart xenograft survival in cyclosporine-treated baboons. Transplant Proc 24, 508-510 (1992)

40. MS Roslin, RE Tranbaugh, A Panza, MS Coons, YD Kim, T Chang, JN Cunningham & AJ Norin: One year monkey heart xenograft survival in cyclosporine-treated baboons. Transplantation 54, 949-955 (1992)

41. JA Myburgh, JA Smit & JH Stark: Transplantation tolerance following total lymphoid irradiation in baboon-to-vervet monkey kidney xenotransplantation. Transplant Proc 26, 1080-1081 (1994)

42. M Kawauchi, SR Gundry, J Alonso De Begona, AJ Razzouk, F Bouchart, N Fukushima, AJ Hauck, DA Weeks, S Nehlsen-Cannarella & LL Bailey: Prolonged survival of orthotopically transplanted heart xenografts in infant baboons. J Thorac Cardiovasc Surg 106, 779-786 (1993)

43. F Xiao, AS Chong, P Foster, H Sankary, L Mcchesney, JM Williams, D Frieders & JW Williams: Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Transplant Proc 26, 1263-1265 (1994)

44. F Xiao, AS Chong, P Foster, H Sankary, L Mcchesney, G Koukoulis, J Yang, D Frieders & JW Williams: Leflunomide controls rejection in hamster-to-rat cardiac xenografts. Transplantation 58, 828-834 (1994)

45. CA Cosenza, DV Cramer, PJ Tuso, FA Chapman, HK Wang & L Makowka: Combination therapy with brequinar sodium and cyclosporine synergistically prevents hamster-to-rat cardiac xenograft survival. J Heart Lung Transplant 13, 489-497 (1994)

46. DV Cramer, FA Chapman, BD Jaffee, I Zajac, G Hreha-Eiras, C Yasunaga, GD Wu & L Makowka: The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium. Transplantation 54, 403-408 (1992)

47. JR Leventhal, HC Flores, SA Gruber, J Figueroa, JL Platt, JC Manivel, FH Bach, AJ Matas & RM Bolman III: Evidence that 15-deoxyspergualin inhibits natural antibody production, but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 54, 26-31 (1992)

48. N Murase, TE Starzl, AJ Demetris, L Valdivia, M Tanabe, D Carmer & L Makowka: Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 54, 701-707 (1993)

49. S Hayashi, M Ito, I Yokoyama, K Uchida & H Takagi: Effectiveness of combination therapy using cobra venom factor, spl.enectomy, and deoxyspergualin in guinea pig-to-rat cardiac xenografts. Transplant Proc 25, 405-406 (1993)

50. FT Thomas, MA Tepper, JM Thomas & CE Haisch: 15-deoxyspergualin: a novel immunosuppressive drug with clinical potential. Ann NY Acad Sci 685, 175-192 (1993)

51. K Ulrichs, H Wang & W Muller-Ruchholz: Down-regulation of xenophile antibodies by 15-deoxyspergualin in an experimental animal model. Transplant Proc 26, 994-996 (1994)

52. F De St. J Van Der Riet, PA Human, DKC Cooper, B Reichart, JE Fincham, SS Kalter, PJ Kanki, M Essex, DL Madden, MT Lai-Tung, D Chalton & JL Sever: Virological implications of the use of primates in xenotransplantation. Transplant Proc 19, 4068-4069 (1987)

53. LE Chapman, TM Folks, DR Salomon, AP Patterson, TE Eggerman & PD Noguchi: Xenotransplantation and xenogeneic infection. N Engl J Med 333, 1498-1501 (1995)

54. Y Luo, S Taniguchi, T Kobayashi, M Niekrasz & DKC Cooper: Screening of baboons as potential liver donors for humans. Xenotransplantation 2, 244-252 (1995)

55. JS Allan: Xenotransplantation at a crossroads: prevention versus progress. Nature Med 2, 18-21 (1996)

56. GPJ Alexandre, P Gianello, D Latinne, M Carlier, A Dewaele, L Van Obbergh, M Moriau, E Marbaix, JL Lambotte, L Lambotte, & JP Squifflet: Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Xenograft 25, Ed: MA Hardy, Elsevier, New York, 259-266 (1989)

57. TJ Kroshus, AP Dalmasso, JR Leventhal, R John, AJ Matas & RM Bolman III: Antibody removal by column immunoadsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection. J Surg Res 59, 43-50 (1995)

58. JR Leventhal, P Sakiyalak, J Whitson, P Simone, AJ Matas, RM Bolman III & AP Dalmasso: Synergistic effect of combined antibody and complement depletion upon discordant cardiac xenograft survival in nonhuman primates. Transplantation 57, 974-978 (1994)

59. FA Neethling, E Koren, Y Ye, SV Richards, M Kujundzic, R Oriol & DKC Cooper: Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by alpha-galactosyl oligosaccharides. Transplantation 57, 959-963 (1994)

60. Y Ye, FA Neethling, M Niekrasz, SV Richards, E Koren, H Merhav, S Kosanke, R Oriol & DKC Cooper: Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 58, 330-337 (1994)

61. DKC Cooper, TDH Cairns & DH Taube: Extracorporeal immunoadsorption of anti-pig antibody in baboons using alphaGal oligosaccharide immunoaffinity columns. Xeno In press

62. AD Bannett, RF Mcalack, R Raja, A Baquero & M Morris: Experiences with known ABO-mismatched renal transplants. Transplant Proc 19, 4543-4546 (1987)

63. WI Bensinger, CD Buckner & RA Clift: Whole blood immunoadsorption of anti-A or anti-B antibodies. Vox Sang 48, 357-361 (1985)

64. WI Bensinger, DA Baker, CD Buckner, RA Clift & ED Thomas: Immunoadsorption for removal of A and B blood group antibodies. N Engl J Med 304, 160-162 (1981)

65. FH Bach, MA Turman, GM Vercellotti, JL Platt & AP Dalmasso: Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 23, 205-207 (1991)

66. JL Platt, GM Vercellotti, AP Dalmasso, AJ Matas, RM Bolman III, JS Najarian & FH Bach: Transplantation of discordant xenografts: a review of progress. Immunol Today 11, 450-456 (1990)

67. DKC Cooper, Y Ye, M Niekrasz, M Kehoe, M Martin, FA Neethling, S Kosanke, L Debault, G Worsley, N Zuhdi, R Oriol & DKC Cooper: Specific intravenous carbohydrate therapy - a new concept in inhibiting antibody-mediated rejection: experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 56, 769-777 (1993)

68. DKC Cooper, Y Ye, M Kehoe, M Niekrasz, LL Rolff, M Martin, J Baker, S Kosanke, N Zuhdi, G Worsley & E Romano: A novel approach to "neutralization" of pre-formed antibodies: cardiac allotransplantation across the ABO blood group barrier as a paradigm of discordant xenotransplantation. Transplant Proc 24, 566-571 (1992)

69. DKC Cooper, AH Good, AJ Malcolm, Y Ye, M Niekrasz, E Koren, FA Neethling, RM Ippolito, G Worsley, R Oriol, N Zuhdi & E Romano: Specific intravenous carbohydrate therapy - a new approach to the inhibition of antibody mediated rejection following ABO-incompatible allografting and discordant xenografting. Transplant Proc 25, 377-378 (1993)

70. FA Neethling, D Joziasse, N Bovin, DKC Cooper & R Oriol: The reducing end of alphaGal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera. Transplant Int 9, 98-101 (1996)

71. S Li, J-C Yeh, DKC Cooper & RD Cummings: Inhibition of human anti-alphaGal IgG by oligosaccharides derived from porcine stomach mucin. Xenotransplantation 2, 279-288 (1995)

72. S Li, FA Neethling, S Taniguchi, J-C Yeh, T Kobayashi, Y Ye, E Koren, RD Cummings & DKC Cooper: Glycans derived from porcine stomach mucin are effective inhibitors of natural anti-alphaGal antibodies in vitro and following intravenous infusion in baboons. Transplantation In press

73. E Koren, F Milotec, FA Neethling, M Koscec, M Kujundzic, T Kobayashi, S Taniguchi, M Reichlin & DKC Cooper: Murine monoclonal anti-idiotypic antibodies directed against human anti-alphaGal antibodies prevent rejection of pig cells in culture: implications for pig-to-human organ xenotransplantation. Transplant Proc 28, 559 (1996)

74. E Koren, F Milotec, FA Neethling M Koscec, D Fei, T Kobayashi, S Taniguchi & DKC Cooper: Monoclonal anti- idiotypic antibodies neutralize cytotoxic effects of anti-alphaGal antibodies. Transplantation In press

75. SK Pruitt, WM Baldwin, HC Marsh Jr, SS Linn, CG Yeh & RR Bollinger: The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52, 868-873 (1991)

76. W Xia, DT Fearon & RL Kirkman: Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. Transplant Proc 25, 410-411 (1993)

77. M Chrupcala, S Pomer, G Staehler, R Waldherr & C Kirschfink: Prolongation of discordant renal xenograft survival by depletion of complement Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea pig to rat model. Transpl Int 7, S650 (1994)

78. SK Pruitt, AD Kirk, RR Bollinger, HC Marsh Jr, BH Collins, JL Levin, JR Mault, JS Heinle, S Ibrahim & AR Rudolph: The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363-370 (1994)

79. HC Marsh & US Ryan: The therapeutic effect of soluble complement receptor type I (SCR1) in xenotransplantation. In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

80. JW Homeister, PS Satoh, KS Kilgore & BR Lucchesi: Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. J Immunol 150, 1055-1064 (1993)

81. HF Weisman, T Bartow, MK Leppo, HC Marsh Jr, GR Carson, MF Concino, MP Boyle, KH Roux, ML Weisfeldt & DT Fearon: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-151 (1990)

82. F Sanfilippo: Effects of complement inhibitors on discordant rodent and pig-to-primate cardiac xenograft rejection. Presented to the Third International Congress for Xenotransplantation, Boston (1995)

83. JA Smit, JH Stark & JA Myburgh: Mechanism of immunological tolerance following total lymphoid irradiation. Transplant Proc 19, 490-492 (1987)

84. JA Myburgh, JA Smit & JH Stark: Transplantation tolerance following total lymphoid irradiation in baboon-to-vervet monkey kidney xenotransplantation Transplant Proc 26, 1080-1081 (1994)

85. JA Myburgh, JA Smit & JH Stark: Experimental concordant kidney xenotransplantation in primates In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

86. Y Sharabi & DH Sachs: Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169, 493-502 (1989)

87. Y Sharabi, I Aksentijevich, TM Sundt III, DH Sachs & M Sykes: Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 172, 195-202 (1990)

88. Y Sharabi, VS Abraham, M Sykes & DH Sachs: Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 9, 191-197 (1992)

89. T Kawai, AB Cosimi, RB Colvin, J Powelson, J Eason, T Kozlowski, M Sykes, R Monroy, M Tanaka & DS Sachs: Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59, 256-262 (1995)

90. D Latinne, P Gianello, CV Smith, V Nickeleit, T Kawai, M Beadle, C Haug, M Sykes, E Lebowitz, & H Bazin: Xenotransplantation from pig to cynomolgus monkey: an approach toward tolerance induction. Transplant Proc 250, 336- 338 (1993)

91. M Tanaka, D Latinne, P Gianello, T Sablinski, T Lorf, M Bailin, V Nickeleit, R Colvin, E Lebowitz & M Sykes: Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism. Transplant Proc 26, 1326-1327 (1994)

92. T Sablinski, D Latinne, P Gianello, M Bailin, K Bergen, RB Colvin, A Foley, H-Z Hong, T Lorf, S Meehan, R Monroy, JA Powelson, M Sykes, M Tanaka, AB Cosimi & DH Sachs: Xenotransplantation of pig kidneys to nonhuman primates: I Development of a model. Xenotransplantation 2, 264-270 (1995)

93. M Sykes & DH Sachs: Xenogeneic tolerance through hematopoietic cell and thymic transplantation In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

94. G Hansch, CH Hammer, P Vanguri & ML Shin: Homologous species restriction in lysis of erythrocytes by terminal complement proteins. Proc Natl Acad Sci USA 78, 5118-5121 (1981)

95. C Ish, GL Ong, N Desai & MJ Mattes: The specificity of alternative complement pathway-mediated lysis of erythrocytes: the survey of complement and target cells from 25 species. Scand J Immunol 38, 113-122 (1993)

96. E Cozzi & DJG White: The generation of transgenic pigs as potential organ donors for humans. Nature Med 1, 964-966 (1995)

97. DJG White, GA Langford, E Cozzi & VJ Young: Production of pigs transgenic for human DAF A strategy for xenotransplantation. Xenotransplantation 2, 213-217 (1995)

98. E Cozzi, N Yannoutsos, GA Langford, J Pino-Chavez, J Wallwork & DJG White: The effect of transgenic expression of human decay accelerating factor on the inhibition of hyperacute rejection of pig organs. In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

99. KR Mccurry, DL Kooyman, CG Alvarado, AH Cotterell, MJ Martin, JS Logan & JL Platt: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1, 423-427 (1995)

100. WL Fodor, TJ Kroshus, SA Rollins et al: Engineering transgenic pig organs to assist hyperacute rejection in pig-to- primate xenotransplantation. Presented to the Third International Congress for Xenotransplantation, Boston, (1995) (Abstract po-31)

101. DJG White, R Braidley, J Dunning, et al: Hearts from pigs transgenic for human DAF are not hyperacutely rejected when xenografted to primates. Presented to the Third International Congress for Xenotransplantation, Boston, (1995) (Abstract pl-28)

102. DKC Cooper, E Koren, & R Oriol: Genetically-engineered pigs. Lancet 342, 682-683 (1993) 103. ERG Tearle, MJ Tange, ZL Zannettino, M Katerelos, TA Shinkel, BJW Van Denderen, AJ Lonie, I Lyons, MB Nottle, T Cox, C Becker, AM Peura, PL Wigley, RJ Crawford, AJ Robbins, MJ Pearse & AJF d'Apice: The alpha1,3- galactosyltransferase knockout mouse - implications for xenotransplantation. Transplantation 61, 13-19 (1996)

104. AD Thall, P Maly & JB Lowe: Gal alpha1,3Gal epitopes implicated in sperm adhesion to the zono pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 270, 21437-21440 (1995)

105. MS Sandrin, WL Fodor, E Mouhtouris, N Osman, S Cohney, SA Rollins, ER Guilmette, E Setter, SP Squinto & IFC Mckenzie: Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med 1, 1261-1267 (1995)

106. MS Sandrin, S Cohney, N Osman & IFC Mckenzie: Overcoming the anti-Gala1-3Gal reaction to avoid hyperacute rejection: molecular genetic approaches. In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

107. DKC Cooper, E Koren, & R Oriol: Manipulation of the anti-alphaGal antibody - alphaGal epitope system in experimental discordant xenotransplantation Xenotransplantation 3, 102-111 (1996)

108. RP Lanza & WL Chick: Pancreatic Islet Transplantation, Volumes I-III RG Landes, Austin (1994)

109. DKC Cooper, Y Ye, LL Rolf Jr & N Zuhdi: The pig as potential organ donor for man. In: Xenotransplantation, (First edition), Eds: DKC Cooper, E Kemp, K Reemtsma & DJG White: Springer, Heidelberg, 481-500 (1991)

110. The Gallup Organization Inc The American Public's Attitudes Toward Organ Donation and Transplantation. Conducted for the Partnership for Organ Donation, Boston (1993)

111. JM Chen & RE Michler: Heart xenotransplantation: lessons learned and future prospects. J Heart Lung Transplant 12, 869-875 (1993)

112. RC Fox & JP Swazey: Experimental therapy dilemma. In: The Courage to Fail. University of Chicago, Chicago, p 60 (1974)

113. Moses, RD & Auchincloss, H Jr Mechanism of celluar xenograft rejection. In: Xenotransplantation, (First edition), Eds: DKC Cooper, E Kemp, K Reemtsma & DJG White, Springer, Heidelberg, 101-120 (1991)

114. RD Moses & H Auchincloss Jr: Mechanism of cellular xenograft rejection. In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

115. C Hammer: Evolutionary obstacles to xenotransplantation. In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

116. Abouna, GM Extracorporeal xenogeneic liver perfusion for the treatment of hepatic failure. In: Xenotransplantation, (Second edition), Eds: DKC Cooper, E Kemp, JL Platt & DJG White, Springer, Heidelberg In press

117. BH Collins, RS Chari, JC Magee, RC Harland, BJ Lindman, JS Logan, RR Bollinger, WC Meyers & JL Platt: Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure. Transplantation 58, 1162-1171 (1994)

[Table of Contents ] [Previous Section]